CRISPR Therapeutics AG - Common Shares (NQ:CRSP)
51.96
+3.18
(+6.51%)
Streaming Delayed Price
Updated: 11:15 AM EDT, Apr 27, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,498,934 |
| Open | 50.59 |
| Bid (Size) | 51.95 (100) |
| Ask (Size) | 51.96 (400) |
| Prev. Close | 48.78 |
| Today's Range | 50.50 - 54.04 |
| 52wk Range | 33.03 - 78.48 |
| Shares Outstanding | 78,935,098 |
| Dividend Yield | N/A |
Top News
More News
3 Biotech Stocks That Could Benefit from the Patent Cliff ↗
Today 7:05 EDT
Via MarketBeat
Topics
Intellectual Property
Performance
| YTD |
-3.4%
|
-3.4%
|
| 1 Month |
+13.6%
|
+13.6%
|
| 3 Month |
-4.9%
|
-4.9%
|
| 6 Month |
-20.9%
|
-20.9%
|
| 1 Year |
+37.2%
|
+37.2%
|
More News
Read More
2 Billion Reasons to Love CRISPR Therapeutics Right Now ↗
April 13, 2026
Via The Motley Fool
Via The Motley Fool
Topics
ETFs
CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗
March 23, 2026
Via The Motley Fool
Via Finterra
Topics
Intellectual Property
Is CRISPR Therapeutics Stock a Buy Now? ↗
March 20, 2026
Via The Motley Fool
3 Monster Stocks to Hold for the Next 10 Years ↗
March 10, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Via The Motley Fool
Why Is CRSP Stock Falling Pre-Market Today? ↗
March 10, 2026
Via Stocktwits
Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? ↗
March 02, 2026
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
March 01, 2026
Via The Motley Fool
Topics
ETFs
Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off? ↗
February 20, 2026
Via The Motley Fool
Via The Motley Fool
Topics
ETFs
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗
February 19, 2026
Via MarketBeat
Should You Buy Shares of CRISPR Therapeutics in February? ↗
February 18, 2026
Via The Motley Fool
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
January 30, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch ↗
January 29, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 51.96
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 04/27/26 11:15 AM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.10B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>